Annual Total Liabilities
$57.66 M
+$47.17 M+449.86%
December 1, 2023
Summary
- As of February 7, 2025, ORMP annual total liabilities is $57.66 million, with the most recent change of +$47.17 million (+449.86%) on December 1, 2023.
- ORMP annual total liabilities is now at all-time high.
Performance
ORMP Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$9.56 M
+$1.49 M+18.47%
September 1, 2024
Summary
- As of February 7, 2025, ORMP quarterly total liabilities is $9.56 million, with the most recent change of +$1.49 million (+18.47%) on September 1, 2024.
- Over the past year, ORMP quarterly total liabilities has dropped by -$48.10 million (-83.42%).
- ORMP quarterly total liabilities is now -88.44% below its all-time high of $82.66 million, reached on September 30, 2023.
Performance
ORMP Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
ORMP Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +449.9% | -83.4% |
| 3 y3 years | - | +3.3% |
| 5 y5 years | +277.6% | -37.4% |
ORMP Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +449.9% | -88.4% | +68.9% |
| 5 y | 5-year | at high | +449.9% | -88.4% | +68.9% |
| alltime | all time | at high | >+9999.0% | -88.4% | >+9999.0% |
Oramed Pharmaceuticals Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $9.56 M(+18.5%) |
| Jun 2024 | - | $8.07 M(-78.7%) |
| Mar 2024 | - | $37.93 M(-34.2%) |
| Dec 2023 | $57.66 M(+449.9%) | $57.66 M(-30.2%) |
| Sep 2023 | - | $82.66 M(+1360.7%) |
| Jun 2023 | - | $5.66 M(-41.2%) |
| Mar 2023 | - | $9.63 M(-8.1%) |
| Dec 2022 | $10.49 M(-6.5%) | $10.49 M(-7.1%) |
| Sep 2022 | - | $11.29 M(+22.0%) |
| Jun 2022 | - | $9.25 M(-7.5%) |
| Mar 2022 | - | $10.00 M(-15.0%) |
| Dec 2021 | $11.21 M(-2.4%) | - |
| Nov 2021 | - | $11.76 M(+2.4%) |
| Aug 2021 | $11.48 M(-2.3%) | $11.48 M(+1.6%) |
| May 2021 | - | $11.30 M(-7.5%) |
| Feb 2021 | - | $12.21 M(-4.3%) |
| Nov 2020 | - | $12.76 M(+8.6%) |
| Aug 2020 | $11.75 M(-23.0%) | $11.75 M(-2.4%) |
| May 2020 | - | $12.04 M(-12.7%) |
| Feb 2020 | - | $13.79 M(-1.4%) |
| Nov 2019 | - | $13.98 M(-8.4%) |
| Aug 2019 | $15.27 M(-6.2%) | $15.27 M(-3.8%) |
| May 2019 | - | $15.88 M(-3.6%) |
| Feb 2019 | - | $16.46 M(+11.7%) |
| Nov 2018 | - | $14.73 M(-9.5%) |
| Aug 2018 | $16.29 M(-16.4%) | $16.29 M(-9.5%) |
| May 2018 | - | $18.00 M(+1.3%) |
| Feb 2018 | - | $17.77 M(-5.5%) |
| Nov 2017 | - | $18.80 M(-3.4%) |
| Aug 2017 | $19.47 M(+17.0%) | $19.47 M(-2.5%) |
| May 2017 | - | $19.98 M(-2.6%) |
| Feb 2017 | - | $20.51 M(-2.0%) |
| Nov 2016 | - | $20.94 M(+25.9%) |
| Aug 2016 | $16.64 M(+990.4%) | $16.64 M(+212.7%) |
| May 2016 | - | $5.32 M(-6.1%) |
| Feb 2016 | - | $5.67 M(+322.3%) |
| Nov 2015 | - | $1.34 M(-12.1%) |
| Aug 2015 | $1.53 M | $1.53 M(+90.3%) |
| May 2015 | - | $802.00 K(+25.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Feb 2015 | - | $641.00 K(-25.7%) |
| Nov 2014 | - | $863.00 K(-14.5%) |
| Aug 2014 | $1.01 M(+90.7%) | $1.01 M(+91.5%) |
| May 2014 | - | $527.00 K(+37.9%) |
| Feb 2014 | - | $382.20 K(-45.4%) |
| Nov 2013 | - | $700.40 K(+32.4%) |
| Aug 2013 | $529.00 K(-65.1%) | $529.00 K(-23.0%) |
| May 2013 | - | $687.10 K(-3.1%) |
| Feb 2013 | - | $709.30 K(+23.4%) |
| Nov 2012 | - | $575.00 K(-62.1%) |
| Aug 2012 | $1.52 M(+152.0%) | $1.52 M(+201.7%) |
| May 2012 | - | $502.70 K(-32.5%) |
| Feb 2012 | - | $744.20 K(+27.2%) |
| Nov 2011 | - | $585.20 K(-2.8%) |
| Aug 2011 | $602.00 K(-3.0%) | $602.00 K(+15.4%) |
| May 2011 | - | $521.80 K(-28.3%) |
| Feb 2011 | - | $727.90 K(+33.7%) |
| Nov 2010 | - | $544.40 K(-12.3%) |
| Aug 2010 | $620.60 K(+20.3%) | $620.60 K(+43.2%) |
| May 2010 | - | $433.40 K(+0.9%) |
| Feb 2010 | - | $429.40 K(-23.1%) |
| Nov 2009 | - | $558.60 K(+8.3%) |
| Aug 2009 | $515.70 K(-43.6%) | $515.70 K(+8.6%) |
| May 2009 | - | $475.00 K(-12.7%) |
| Feb 2009 | - | $543.80 K(-17.6%) |
| Nov 2008 | - | $660.20 K(-27.8%) |
| Aug 2008 | $914.00 K(-35.8%) | $914.00 K(-61.3%) |
| May 2008 | - | $2.36 M(+151.7%) |
| Feb 2008 | - | $939.00 K(+4.9%) |
| Nov 2007 | - | $895.00 K(-37.1%) |
| Aug 2007 | $1.42 M(+133.9%) | $1.42 M(-18.1%) |
| May 2007 | - | $1.74 M(+142.9%) |
| Feb 2007 | - | $715.90 K(+26.1%) |
| Nov 2006 | - | $567.70 K(-6.8%) |
| Aug 2006 | $608.90 K(+1220.8%) | $608.90 K(+64.7%) |
| May 2006 | - | $369.70 K(+619.3%) |
| Feb 2006 | - | $51.40 K(+3.2%) |
| Nov 2005 | - | $49.80 K |
| Aug 2005 | $46.10 K | - |
FAQ
- What is Oramed Pharmaceuticals annual total liabilities?
- What is the all time high annual total liabilities for Oramed Pharmaceuticals?
- What is Oramed Pharmaceuticals annual total liabilities year-on-year change?
- What is Oramed Pharmaceuticals quarterly total liabilities?
- What is the all time high quarterly total liabilities for Oramed Pharmaceuticals?
- What is Oramed Pharmaceuticals quarterly total liabilities year-on-year change?
What is Oramed Pharmaceuticals annual total liabilities?
The current annual total liabilities of ORMP is $57.66 M
What is the all time high annual total liabilities for Oramed Pharmaceuticals?
Oramed Pharmaceuticals all-time high annual total liabilities is $57.66 M
What is Oramed Pharmaceuticals annual total liabilities year-on-year change?
Over the past year, ORMP annual total liabilities has changed by +$47.17 M (+449.86%)
What is Oramed Pharmaceuticals quarterly total liabilities?
The current quarterly total liabilities of ORMP is $9.56 M
What is the all time high quarterly total liabilities for Oramed Pharmaceuticals?
Oramed Pharmaceuticals all-time high quarterly total liabilities is $82.66 M
What is Oramed Pharmaceuticals quarterly total liabilities year-on-year change?
Over the past year, ORMP quarterly total liabilities has changed by -$48.10 M (-83.42%)